Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway

Introduction: Cerebroprotein hydrolysate has been proven to improve cognitive function in patients with Alzheimer’s disease (AD). We explored the safety and effectiveness of the clinical administration of oral cerebroprotein hydrolysate in AD, and possible mechanisms related to the neuronal ferropto...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Moxi, Song, Wei, Chen, Zhengju, Shi, Xiaodong, Wang, Xue, Li, Rongrong, Hao, Honglin, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154667/
https://www.ncbi.nlm.nih.gov/pubmed/37153800
http://dx.doi.org/10.3389/fphar.2023.1177503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154667/
https://www.ncbi.nlm.nih.gov/pubmed/37153800
http://dx.doi.org/10.3389/fphar.2023.1177503

Ejemplares similares